NeuKana Tablet (Calidino Genase)

Adult dose

Administer 30~150I.U. orally in 3 divided doses (take, use). Adjust the dose appropriately according to age and symptoms.

This medication should not be used in patients with bleeding issues such as cerebral hemorrhage. This medication contains lactose and should not be administered to patients with genetic disorders that prevent lactose digestion. Additionally, this medication contains a dye called Yellow No. 5, so patients with allergies or hypersensitivity to this ingredient should use it with caution. If skin rash or itching occurs during use, the medication should be discontinued immediately. Rarely, symptoms such as heart palpitations may occur, so caution is necessary. Gastrointestinal symptoms may include discomfort in the stomach, nausea, vomiting, decreased appetite, abdominal pain, diarrhea, or constipation. Other symptoms such as feeling hot, headaches, drowsiness, and fatigue may occur rarely. Elderly individuals may have decreased bodily function, so caution should be exercised by adjusting the dosage when using this medication.

• rash
• itching
• palpitations
• abdominal discomfort
• nausea
• vomiting
• loss of appetite
• upper abdominal pain
• diarrhea
• constipation

This medication should be stored in a tightly sealed container to prevent air or moisture ingress. It is recommended to keep the storage temperature between 1 to 30 degrees Celsius at room temperature. This will help maintain the medication's effectiveness safely.

Appearance

Orange round enteric-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle